Press Releases | Medtronic

Month Year

Email alerts

Sep 20, 2010

Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study

Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device

WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
Sep 17, 2010

Newly Published Data Show Occipital Nerve Stimulation May Be a Promising New Therapy for Chronic Migraine

Initial Results Suggest ONS Warrants Further Study for Control of Chronic Migraine

MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...
Sep 17, 2010

Medtronic Showcases Cardiovascular Devices at TCT 2010

Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...
Sep 16, 2010

Medtronic Receives European CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy

Further Clinical Study Required for Application to U.S. Food and Drug Administration

MINNEAPOLIS, Sep 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain...
Sep 14, 2010

Medtronic CFO Gary Ellis to Speak at UBS Global Life Sciences Conference

MINNEAPOLIS, Sep 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the UBS Global Life Sciences...
Sep 13, 2010

Medtronic Introduces New CareLink(R) Remote Monitoring Network for Heart Failure Clinicians

System Supports Proactive Patient Care for Patients at Risk for Worsening Heart Failure

MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced the CareLink(R) Network for Heart Failure, an extension of the world's largest remote implantable cardiac...
Sep 13, 2010

Medtronic Continues Membership in the Dow Jones Sustainability Index and FTSE4Good Index

Medical Device Leader Recognized for Corporate Sustainability

MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
Sep 10, 2010

Medtronic Releases 2010 Corporate Citizenship Report

"Innovating for a Better World" Reviews Company's Economic, Social and Environmental Performance for Fiscal Year 2010

MINNEAPOLIS, Sep 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) has released "Innovating for a Better World," the company's 2010 Corporate Citizenship Report. The online report, which...
Sep 7, 2010

Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK

Resolute Integrity Stent Launched in the UK Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the...
Sep 7, 2010

Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer

Innovative Technology Advances Greater Ease of Use Advantage for Physicians During CoreValve Transcatheter Valve Implantation

MINNEAPOLIS, Sep 07, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européenne) Mark approval and the first global use and launch of the Medtronic...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa